Outlook Therapeutics, Inc. (OTLK)
0.6405
-0.03
(-3.90%)
USD |
NASDAQ |
Sep 08, 16:00
0.6453
0.00 (0.00%)
Pre-Market: 09:16
Outlook Therapeutics Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 29, 2023 | 39.89 |
| June 28, 2023 | 40.75 |
| June 27, 2023 | 40.38 |
| June 26, 2023 | 38.67 |
| June 23, 2023 | 42.83 |
| June 22, 2023 | 42.34 |
| June 21, 2023 | 42.83 |
| June 20, 2023 | 43.32 |
| June 16, 2023 | 44.30 |
| June 15, 2023 | 43.56 |
| June 14, 2023 | 41.11 |
| June 13, 2023 | 40.14 |
| June 12, 2023 | 40.38 |
| June 09, 2023 | 42.34 |
| June 08, 2023 | 42.58 |
| June 07, 2023 | 46.25 |
| June 06, 2023 | 43.81 |
| June 05, 2023 | 42.83 |
| June 02, 2023 | 39.28 |
| June 01, 2023 | 39.89 |
| May 31, 2023 | 36.71 |
| May 30, 2023 | 36.71 |
| May 26, 2023 | 36.10 |
| May 25, 2023 | 33.04 |
| May 24, 2023 | 36.46 |
| Date | Value |
|---|---|
| May 23, 2023 | 37.20 |
| May 22, 2023 | 39.89 |
| May 19, 2023 | 32.79 |
| May 18, 2023 | 29.86 |
| May 17, 2023 | 29.37 |
| May 16, 2023 | 29.12 |
| May 15, 2023 | 29.37 |
| May 12, 2023 | 28.14 |
| May 11, 2023 | 27.65 |
| May 10, 2023 | 28.88 |
| May 09, 2023 | 28.63 |
| May 08, 2023 | 27.90 |
| May 05, 2023 | 28.14 |
| May 04, 2023 | 27.16 |
| May 03, 2023 | 27.41 |
| May 02, 2023 | 27.16 |
| May 01, 2023 | 28.63 |
| April 28, 2023 | 25.70 |
| April 27, 2023 | 25.94 |
| April 26, 2023 | 26.43 |
| April 25, 2023 | 26.68 |
| April 24, 2023 | 26.68 |
| April 21, 2023 | 28.63 |
| April 20, 2023 | 29.12 |
| April 19, 2023 | 28.14 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Valion Bio, Inc. | 0.0978 |
| Agenus, Inc. | -- |
| Amgen, Inc. | 18.19 |
| Anika Therapeutics, Inc. | 2.051 |
| BioCryst Pharmaceuticals, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 116.60 |
| Price | 0.6405 |
| Earnings Yield | -176.6% |
| Market Cap | 119.84M |